An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives
Tuberculosis (TB) is currently the leading cause of mortality due to an infectious disease, despite the existence of multiple effective first-line and second-line drugs. The current anti-TB regimen requires a prolonged treatment period of around 6 months and is only efficacious against drug-sensitiv...
Saved in:
Main Authors: | Lloyd Tanner (Author), Richard K. Haynes (Author), Lubbe Wiesner (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria
by: Daniel J. Watson, et al.
Published: (2022) -
Accumulation of TB-Active Compounds in Murine Organs Relevant to Infection by Mycobacterium tuberculosis
by: Lloyd Tanner, et al.
Published: (2020) -
Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins
by: Daniel J. Watson, et al.
Published: (2024) -
Elucidating the Antimycobacterial Mechanism of Action of Decoquinate Derivative RMB041 Using Metabolomics
by: Kirsten E. Knoll, et al.
Published: (2021) -
An integrated assessment of the ADME properties of the CDK4/6 Inhibitor ribociclib utilizing preclinical in vitro, in vivo, and human ADME data
by: Alexander D. James, et al.
Published: (2020)